Jan Weber

3.2k citations
105 papers · 2.7k · h-index 26

Impact in

  • Virology top 1%
    • HIV Research and Treatment
    • HIV/AIDS drug development and treatment
    • SARS-CoV-2 and COVID-19 Research

Papers in

    • HIV/AIDS drug development and treatment 37
    • SARS-CoV-2 and COVID-19 Research 9
    • HIV Research and Treatment 20

Jan Weber

102 papers receiving 2.6k citations

Peers

Jan Weber
Comparison fields: 5 of 106
  • Virology 614
  • Infectious Diseases 790
  • Microbiology 247
  • Drug Discovery 3
  • Biomaterials 114
Replace Fred C. Krebs with:
Fred C. Krebs United States
Mohammad Reza Aghasadeghi Iran
Sunil Shaunak United Kingdom
Aarthi Narayanan United States
Lucy Rutten Netherlands
Chung‐Yi Wu Taiwan
Shuishu Wang United States
Jonathan R. Lai United States
Qinxue Hu China
Pele Choi-Sing Chong Taiwan
Jan Weber relative to Fred C. Krebs United States Fred C. Krebs's profile →
Citations per field
00.5×1.5×2×2.4×
Fred C. Krebs · 1×
Citations per year

Countries citing papers authored by Jan Weber

Since Specialization
Citations

This map shows the geographic impact of Jan Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Weber more than expected).

Fields of papers citing papers by Jan Weber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Weber. The network helps show where Jan Weber may publish in the future.

Co-authors

The 25 scholars most cited alongside Jan Weber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan Weber Line = papers co-authored together Jan Weber links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2003375
2 2017364
3 2001104
4 201682
5 198975
6 200574
7 200372
8 200869
9 201269
10 201658
11 201557
12 201655
13 200246
14 201744
15 200643
16 202042
17 202040
18 200238
19 200335
20
HIV type 1 tropism and inhibitors of viral entry: clinical implications.
200635

About Jan Weber

Jan Weber is a scholar working on Infectious Diseases, Virology, Organic Chemistry, Epidemiology and Molecular Biology, having authored 105 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (37 papers), HIV Research and Treatment (20 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Hepatitis B Virus Studies (7 papers), Synthesis and Characterization of Heterocyclic Compounds (6 papers), DNA and Nucleic Acid Chemistry (5 papers), Computational Drug Discovery Methods (5 papers) and Synthesis and biological activity (5 papers). The work is most often cited by research in Virology (614 citations), Infectious Diseases (790 citations), Microbiology (247 citations), Drug Discovery (3 citations) and Biomaterials (114 citations). Jan Weber has collaborated with scholars based in Czechia, United States and Germany. Frequent co-authors include Miguel E. Quiñones‐Mateu, Bikram Chakraborty, Jan Hodek, Hector Rafael Rangel, Michael L. Marotta, Michael M. Lederman, Patti K. Kiser, Frank Große, Zhimin Feng and Kathy Medvik. Their work appears in journals such as Scientific Reports, PLoS ONE, Antiviral Research, Antiviral Therapy and Viruses.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact